CRISPR Screen Identifies GATOR1 Complex as Key Suppressor of MYC-Driven Lymphomas with Therapeutic Implications
核心洞察
A genome-wide CRISPR/Cas9 screen in MYC-driven lymphoma (搜索) models identified the GATOR1 (搜索) complex components NPRL3 (搜索) and DEPDC5 (搜索) as potent tumor suppressors that regulate mTORC1 (搜索) signaling.
Loss of any GATOR1 (搜索) component accelerated lymphoma development to levels comparable with p53 deletion, while maintaining wild-type p53 status and obviating pressure for p53 mutations.
GATOR1 (搜索)-deficient lymphomas showed constitutive mTORC1 (搜索) activation and demonstrated exceptional sensitivity to mTORC1 inhibitors like rapamycin, with single-agent treatment achieving cures in mouse models.
Researchers have identified a previously unknown tumor suppressor pathway that could open new therapeutic avenues for treating MYC (搜索)-driven lymphomas. Using an unbiased genome-wide CRISPR/Cas9 screening approach, scientists discovered that the GATOR1 (搜索) complex plays a critical role in suppressing lymphoma development and represents a potential therapeutic vulnerability.
CRISPR Screen Reveals Novel Tumor Suppressors
The research team conducted a comprehensive in vivo CRISPR screen using fetal liver cells from Eμ-Myc (搜索);Cas9 double transgenic mice transduced with a pooled whole-genome sgRNA library containing 87,987 sgRNAs targeting 19,150 mouse protein coding genes. Following transplantation into lethally irradiated recipient mice, they identified 38 hits from 59 lymphoma samples that developed with accelerated kinetics.
The screen successfully identified known tumor suppressors, with p53 being the most prominent hit detected in 13 different lymphomas. However, pathway analysis revealed an unexpected finding: five of the top gene hits - Nprl3 (搜索), Depdc5 (搜索), Tsc1 (搜索), Tsc2 (搜索), and Pdpk1 - function in the mTOR signaling pathway. Notably, Nprl3 and Depdc5 encode essential components of the GATOR1 (搜索) complex, which negatively regulates mTORC1 (搜索) in response to amino acid availability.
GATOR1 Complex Functions as Potent Tumor Suppressor
The GATOR1 (搜索) complex consists of three subunits: NPRL3 (搜索), DEPDC5 (搜索), and NPRL2 (搜索), all required for its function. Individual validation experiments demonstrated that loss of any GATOR1 component significantly accelerated MYC (搜索)-driven lymphomagenesis to a similar extent as p53 deletion. Mice transplanted with sgRNAs targeting Nprl3, Depdc5, or Nprl2 developed lymphomas with median latencies comparable to sgp53-treated mice, compared to ~140 days for control mice.
Analysis of human diffuse large B cell lymphoma (搜索) (DLBCL (搜索)) patient samples revealed that GATOR1 (搜索)-low expression was associated with significantly poorer survival compared to GATOR1-high expression patients in one cohort, suggesting clinical relevance of these findings.
GATOR1 Loss Obviates p53 Mutation Pressure
A striking discovery was that GATOR1 (搜索)-deficient lymphomas maintained wild-type p53 status. While approximately 30% of control Eμ-Myc (搜索) lymphomas acquired p53 pathway defects, none of the 24 GATOR1-deficient lymphomas showed p53 or p19ARF abnormalities. Functional validation using nutlin-3a treatment confirmed that 100% of GATOR1-deficient lymphoma cell lines retained functional wild-type p53, whereas 30% of control lymphomas were resistant due to p53 mutations.
Analysis of human DLBCL (搜索) samples corroborated these findings, showing that mutations in p53 and GATOR1 (搜索) complex genes were mutually exclusive. This suggests that GATOR1 loss provides an alternative pathway to p53 inactivation for lymphoma development.
Constitutive mTORC1 Activation Drives Metabolic Reprogramming
GATOR1 (搜索)-deficient lymphomas exhibited substantially higher levels of phosphorylated S6, a surrogate marker of mTORC1 (搜索) signaling, both under steady-state conditions and during amino acid starvation. Unlike control lymphomas, GATOR1-deficient cells failed to inhibit mTORC1 following removal of leucine, methionine, and arginine - amino acids uniquely sensed by the GATOR1 complex.
RNA-sequencing analysis revealed that GATOR1 (搜索)-deficient lymphomas displayed elevated expression of genes involved in mTORC1 (搜索)-regulated metabolic pathways, including lipid/cholesterol biosynthesis, pentose phosphate pathway, and one-carbon metabolism. Functional assays confirmed increased incorporation of O-propargyl-puromycin into nascent proteins, indicating augmented translation capacity.
Therapeutic Vulnerability to mTORC1 Inhibition
The constitutive mTORC1 (搜索) activation in GATOR1 (搜索)-deficient lymphomas created a therapeutic vulnerability. Treatment with rapamycin potently killed GATOR1-deficient cells in vitro, while control lymphoma cells were highly resistant. Similarly, GATOR1-deficient cells showed sensitivity to Torin1, a dual mTORC1/mTORC2 inhibitor, at clinically relevant doses.
Most remarkably, in vivo experiments demonstrated that single-agent rapamycin treatment for five consecutive days cured most mice transplanted with GATOR1 (搜索)-deficient lymphomas, whereas control lymphomas showed no response. This represents a striking example of synthetic lethality, where loss of GATOR1 function renders lymphomas "addicted" to hyperactive mTORC1 (搜索) signaling.
Clinical Implications and Future Directions
These findings suggest that GATOR1 (搜索) status could serve as a biomarker for mTORC1 (搜索) inhibitor sensitivity in lymphoma patients. The mutual exclusivity between GATOR1 and p53 mutations indicates that these represent alternative pathways to lymphomagenesis, potentially requiring different therapeutic approaches.
The research demonstrates that unbiased CRISPR screening can identify previously unknown tumor suppressor pathways and reveal unexpected therapeutic vulnerabilities. The exceptional sensitivity of GATOR1 (搜索)-deficient lymphomas to mTORC1 (搜索) inhibition suggests that patients with GATOR1-deficient tumors might benefit from mTORC1-targeted therapies, even as single agents.